ABBV - 3 Biotech Stocks That Are Too Cheap to Ignore
There are plenty of biotech stocks that are expensive. Their valuations depend on highly risky pipeline candidates achieving success. But not every biotech stock is priced at a premium.
We asked three Motley Fool contributors to select biotech stocks that are currently available at a discount. Here's why they identified AbbVie (NYSE: ABBV) , Axsome Therapeutics (NASDAQ: AXSM) , and Jazz Pharmaceuticals (NASDAQ: JAZZ) as biotech stocks that are too cheap to ignore.
Image source: Getty Images.
For further details see:
3 Biotech Stocks That Are Too Cheap to Ignore